Cube Pharmaceutical (003020.SZ) released its 2023 annual report. During the reporting period, the company achieved operating income of 1...
According to the Zhitong Finance App, Cube Pharmaceuticals (003020.SZ) released its 2023 annual report. During the reporting period, the company achieved revenue of 1,901 billion yuan, a year-on-year decrease of 26.31%. Achieved net profit attributable to shareholders of listed companies of 227 million yuan, an increase of 8.33% over the previous year. Achieved net profit of 187 million yuan after deducting non-recurring profit and loss attributable to shareholders of listed companies, an increase of 12.15% over the previous year. Basic earnings per share were $1.42. It is proposed to distribute a cash dividend of 5 yuan (tax included) to all shareholders for every 10 shares, and use the capital reserve fund to transfer 2 shares for every 10 shares to all shareholders.